7-(1,3-Dioxolan-2-ylmethyl)-1,3-di-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-9-ium tetrachloridoferrate(III)

被引：0

作者：

Wang, Ping Ping ^{[3
]}

Gong, Jiang ^{[1
,2
]}

Ni, Shi-Feng ^{[1
]}

机构：

[1] Northwest Univ, Coll Life Sci, Minist Educ, Key Lab Resource Biol & Biotechnol Western China, Xian 710069, Peoples R China

[2] Tibet Nationalities Inst, Dept Med, Xianyang 712082, Shaanxi, Peoples R China

[3] Zhejiang Univ Technol, Coll Pharmaceut Sci, Hangzhou 310014, Zhejiang, Peoples R China

来源：

ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE | 2010年 / 66卷

关键词：

TETRACHLOROFERRATE(III);

D O I：

10.1107/S1600536810034720

中图分类号：

O7 [晶体学];

学科分类号：

0702 ; 070205 ; 0703 ; 080501 ;

摘要：

The asymmetric unit of the title compound, (C11H15N4O4)[FeCl4], contains two independent protonated 7-(1,3-dioxolan-2-ylmethyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (doxofyllinium) and two tetrahedral tetrachloridoferrate(III) anions. In the doxofyllinium, two disordered methylene C atoms are observed in each dioxolane ring with an occupancy ratio of 0.54 (4):0.46 (4). In the crystal, molecules are connected by N-H center dot center dot center dot O hydrogen bonds and weak C-H center dot center dot center dot O and C-H center dot center dot center dot Cl interactions.

引用

页码：M1247 / U740

页数：12

共 50 条

[1] (1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-7-yl)(dimethylphenylphosphine)-gold(I)
Pajunen, A
Kivekas, R
Colacio, E
Cuesta, R
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1995, 51 : 2551 - 2554
[2] 7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethylpurine2,6(1H,3H)-dione trichloroacetic acid solvate
Wu, Xiang-Xiang
Shu, Zhan
Ma, Lin-Lin
Ding, Zhe-Wu
Jin, Zhi-Min
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2008, 64 : O347 - U5750
[3] 7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
Chen, Hai-Xiang
Tu, Bing
Shu, Zhan
Ma, Xing-Ju
Jin, Zhi-Min
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2007, 63 : O726 - O727
[4] 7-(1,3-Dioxolan-2-ylmethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione acetic acid solvate
Chen, Zhen-Hua
Tu, Bing
Jin, Zhi-Min
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2007, 63 : O2676 - O2677
[5] 1-(2,6-diisopropylphenyl)-3-(1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8/7-ylalkyl)ureas as potential acyl-CoA:cholesterol acyltransferase inhibitors
Rybár, A
Alföldi, J
Faberová, V
Schmidtová, L'
CHEMICAL PAPERS-CHEMICKE ZVESTI, 2002, 56 (05): : 330 - 339
[6] 1,3-Dimethyl-1H-1,2,3-benzotriazol-3-ium tetrachloridoferrate(III)
Sun, Zan
Hu, Dong-Cheng
Liu, Jia-Cheng
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : M148 - +
[7] Normal coordinate analysis, molecular structure, vibrational and electronic spectral investigation of 7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethylpurine-2,6-dione by ab initio HF and DFT method
Prabakaran, A.
Muthu, S.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2014, 118 : 578 - 588
[8] Synthesis, Biological Evaluation, and Molecular Docking of (R)-2-((8-(3-aminopiperidin-1-yl)-3-methyl-7-(3-methylbut-2-en-1-yl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)benzonitrile as Dipeptidyl Peptidase IV Inhibitors
Ran, Yan
Pei, Heying
Shao, Mingfeng
Chen, Lijuan
CHEMICAL BIOLOGY & DRUG DESIGN, 2016, 87 (02) : 290 - 295
[9] SYNTHESES AND ANTIMICROBIAL ACTIVITIES OF CIS-1-[2-PHENYL-4-(PHENOXY OR PHENYLTHIO)METHYL-1,3-DIOXOLAN-2-YLMETHYL]-1H-IMIDAZOLE DERIVATIVES
TAKEUCHI, I
SUGIURA, M
YAMAMOTO, K
ITO, T
HAMADA, Y
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1985, 105 (06): : 554 - 561
[10] STUDIES ON SPASMOLYTICS .7. PHARMACOLOGICAL PROPERTIES OF 4-BENZILOYLOXY AND 4-(XANTHENE-9-CARBONYLOXY)-1-(1,3-DIOXOLAN-2-YLMETHYL)-1-METHYLPIPERIDINIUM SALTS
SUGAI, S
KAJIWARA, Y
KAWADA, T
KANBARA, T
NAITO, Y
HASEGAWA, Y
YOSHIDA, S
AKABOSHI, S
KUTSUMA, T
TAKAYANAGI, I
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1985, 105 (10): : 990 - 995

← 1 2 3 4 5 →